EMA publishes agenda for 9-12 November CHMP meeting

EMA

12 November 2020 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

  • Bevacizumab
  • Pertuzumab and trastuzumab
  • Netarsudil with latanoprost
  • Baloxavir marboxil

Read CHMP agenda

Michael Wonder

Posted by:

Michael Wonder